These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12572861)

  • 1. Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.
    Itoh H; Kataoka H
    J Gastroenterol; 2002 Nov; 37 Suppl 14():15-21. PubMed ID: 12572861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.
    Kataoka H; Shimomura T; Kawaguchi T; Hamasuna R; Itoh H; Kitamura N; Miyazawa K; Koono M
    J Biol Chem; 2000 Dec; 275(51):40453-62. PubMed ID: 11013244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1).
    Kataoka H; Itoh H; Hamasuna R; Meng JY; Koono M
    Hum Cell; 2001 Mar; 14(1):83-93. PubMed ID: 11436357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor.
    Kataoka H; Miyata S; Uchinokura S; Itoh H
    Cancer Metastasis Rev; 2003; 22(2-3):223-36. PubMed ID: 12784998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice.
    Itoh H; Naganuma S; Takeda N; Miyata S; Uchinokura S; Fukushima T; Uchiyama S; Tanaka H; Nagaike K; Shimomura T; Miyazawa K; Yamada G; Kitamura N; Koono M; Kataoka H
    Gastroenterology; 2004 Nov; 127(5):1423-35. PubMed ID: 15521012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
    Parr C; Jiang WG
    Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatocyte growth factor regulatory factors in human breast cancer.
    Parr C; Watkins G; Mansel RE; Jiang WG
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):202-11. PubMed ID: 14734471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.
    Itoh H; Kataoka H; Tomita M; Hamasuna R; Nawa Y; Kitamura N; Koono M
    Am J Physiol Gastrointest Liver Physiol; 2000 Apr; 278(4):G635-43. PubMed ID: 10762618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of hepatocyte growth factor in monkey stomach following gastric mucosal injury.
    Hori T; Ido A; Uto H; Hasuike S; Moriuchi A; Hayashi K; Nakagawa S; Miyazawa K; Kitamura N; Tsubouchi H
    J Gastroenterol; 2004; 39(2):133-9. PubMed ID: 15069619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
    Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
    J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
    Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis.
    Sasaki M; Ikeda H; Kataoka H; Nakanuma Y
    Virchows Arch; 2006 Oct; 449(4):462-71. PubMed ID: 16941151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
    Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
    J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.
    Yamauchi M; Kataoka H; Itoh H; Seguchi T; Hasui Y; Osada Y
    J Urol; 2004 Feb; 171(2 Pt 1):890-6. PubMed ID: 14713848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis.
    Marchand-Adam S; Fabre A; Mailleux AA; Marchal J; Quesnel C; Kataoka H; Aubier M; Dehoux M; Soler P; Crestani B
    Am J Respir Crit Care Med; 2006 Jul; 174(1):58-66. PubMed ID: 16574935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
    Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B
    Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
    Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
    J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of hepatocyte growth factor activation in cancer tissues.
    Kawaguchi M; Kataoka H
    Cancers (Basel); 2014 Sep; 6(4):1890-904. PubMed ID: 25268161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.